Literature DB >> 6927951

Skeletal osteosarcoma. Animal model: canine osteosarcoma.

W Misdorp.   

Abstract

Entities:  

Mesh:

Year:  1980        PMID: 6927951      PMCID: PMC1903403     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


× No keyword cloud information.
  10 in total

1.  Frequency of osteosarcoma among first-degree relatives of St. Bernard dogs.

Authors:  S Bech-Nielsen; M E Haskins; J S Reif; R S Brodey; D F Patterson; R Spielman
Journal:  J Natl Cancer Inst       Date:  1978-02       Impact factor: 13.506

Review 2.  Primary bone rumors in the dog: a combined clinical, radiographic, and histologic approach to early diagnosis.

Authors:  G V Ling; J P Morgan; R R Pool
Journal:  J Am Vet Med Assoc       Date:  1974-07-01       Impact factor: 1.936

3.  An unusual case of canine osteosarcoma.

Authors:  R R Pool; H G Wolf
Journal:  Cancer       Date:  1974-09       Impact factor: 6.860

4.  Bone infarctions associated with malignant bone tumors in dogs.

Authors:  W H Riser; R S Brodey; D N Biery
Journal:  J Am Vet Med Assoc       Date:  1972-02-15       Impact factor: 1.936

5.  Transplantation of canine osteosarcoma.

Authors:  L N Owen
Journal:  Eur J Cancer       Date:  1969-12       Impact factor: 9.162

6.  Stature and malignant tumors of bone in childhood and adolescence.

Authors:  J F Fraumeni
Journal:  Cancer       Date:  1967-06       Impact factor: 6.860

7.  Canine bone sarcoma: estimation of relative risk as a function of body size.

Authors:  R A Tjalma
Journal:  J Natl Cancer Inst       Date:  1966-06       Impact factor: 13.506

8.  Some prognostic and epidemiologic factors in canine osteosarcoma.

Authors:  W Misdorp; A A Hart
Journal:  J Natl Cancer Inst       Date:  1979-03       Impact factor: 13.506

9.  Tumours of bones and joints.

Authors:  W Misdorp; R O Van der Heul
Journal:  Bull World Health Organ       Date:  1976       Impact factor: 9.408

10.  Tumors associated with metallic implants in animals.

Authors:  K Sinibaldi; H Rosen; S K Liu; M DeAngelis
Journal:  Clin Orthop Relat Res       Date:  1976 Jul-Aug       Impact factor: 4.176

  10 in total
  8 in total

1.  Breed-specific incidence rates of canine primary bone tumors--a population based survey of dogs in Norway.

Authors:  Kristin P Anfinsen; Tom Grotmol; Oyvind S Bruland; Thora J Jonasdottir
Journal:  Can J Vet Res       Date:  2011-07       Impact factor: 1.310

2.  Transcriptional Profiling Identifies the Signaling Axes of IGF and Transforming Growth Factor-b as Involved in the Pathogenesis of Osteosarcoma.

Authors:  Rui Yang; Sajida Piperdi; Yue Zhang; Zhu Zhu; Neophytos Neophytou; Bang H Hoang; Gary Mason; David Geller; Howard Dorfman; Paul A Meyers; John H Healey; Donald G Phinney; Richard Gorlick
Journal:  Clin Orthop Relat Res       Date:  2016-01       Impact factor: 4.176

Review 3.  Strategies for the targeted delivery of therapeutics for osteosarcoma.

Authors:  Dennis P M Hughes
Journal:  Expert Opin Drug Deliv       Date:  2009-12       Impact factor: 6.648

Review 4.  Research models and mesenchymal/epithelial plasticity of osteosarcoma.

Authors:  Xiaobin Yu; Jason T Yustein; Jianming Xu
Journal:  Cell Biosci       Date:  2021-05-22       Impact factor: 7.133

5.  Osteosarcoma models: from cell lines to zebrafish.

Authors:  Alexander B Mohseny; Pancras C W Hogendoorn; Anne-Marie Cleton-Jansen
Journal:  Sarcoma       Date:  2012-03-15

Review 6.  The immunotherapy of canine osteosarcoma: a historical and systematic review.

Authors:  K L Wycislo; T M Fan
Journal:  J Vet Intern Med       Date:  2015-04-30       Impact factor: 3.333

Review 7.  Origin and Therapies of Osteosarcoma.

Authors:  Brice Moukengue; Morgane Lallier; Louise Marchandet; Marc Baud'huin; Franck Verrecchia; Benjamin Ory; Francois Lamoureux
Journal:  Cancers (Basel)       Date:  2022-07-19       Impact factor: 6.575

Review 8.  Animal models in osteosarcoma.

Authors:  Maria V Guijarro; Steven C Ghivizzani; C Parker Gibbs
Journal:  Front Oncol       Date:  2014-07-18       Impact factor: 6.244

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.